Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
3Y CAGR+50.2%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+50.2%/yr
vs +36.1%/yr prior
Acceleration
+14.1pp
Accelerating
Percentile
P100
Near historical high
vs 3Y Ago
3.4x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $111.76M | +344.8% |
| 2024 | $25.12M | -51.4% |
| 2023 | $51.72M | +56.8% |
| 2022 | $32.97M | +204.2% |
| 2021 | $-31.65M | +12.6% |
| 2020 | $-36.21M | -246.9% |
| 2019 | $-10.44M | -208.7% |
| 2018 | $9.60M | +188.5% |
| 2017 | $-10.85M | +69.8% |
| 2016 | $-35.92M | - |